利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

18 条记录 (耗时 0.023 秒)

    Transdermal device having decreased delamination
    5.
    发明授权
    Transdermal device having decreased delamination 失效
    透皮装置具有降低的分层

    公开(公告)号：US5635203A

    公开(公告)日：1997-06-03

    申请号：US315043

    申请日：1994-09-29

    申请人： Robert M. Gale ,  Eun Soo Lee

    发明人： Robert M. Gale ,  Eun Soo Lee

    IPC分类号： A61M37/00 ,  A61K9/70 ,  A61F13/00

    CPC分类号： A61K9/7084

    摘要： A device for the transdermal administration of a drug comprising a microporous tie layer located between the drug reservoir and the contact adhesive. The tie layer eliminates blooming and delamination and has no appreciable adverse effect on either the drug flux or release rate from the device.

    摘要翻译： 用于经皮给药的药物的装置，其包含位于药物储存器和接触粘合剂之间的微孔连接层。 连接层消除了起霜和分层，并且对药物通量或来自装置的释放速率没有明显的不利影响。

    Delayed onset transdermal delivery device
    6.
    发明授权
    Delayed onset transdermal delivery device 失效
    延迟发作透皮递送装置

    公开(公告)号：US5284660A

    公开(公告)日：1994-02-08

    申请号：US933423

    申请日：1992-08-21

    申请人： Eun Soo Lee ,  Felix Theeuwes ,  Patrick S. L. Wong ,  Su Il Yum ,  Robert M. Gale ,  Alejandro Zaffaroni

    发明人： Eun Soo Lee ,  Felix Theeuwes ,  Patrick S. L. Wong ,  Su Il Yum ,  Robert M. Gale ,  Alejandro Zaffaroni

    IPC分类号： A61K9/00 ,  A61K9/22 ,  A61K9/70 ,  A61F13/00

    CPC分类号： A61K9/7084 ,  A61K9/7069 ,  A61K9/7092

    摘要： A diffusional drug delivery device is described which can provide for delayed onset of therapeutic effect and for delivery of the therapeutic agent in predetermined temporal patterns at optimum rates. Delay means are provided between the agent reservoir and the surface through which the agent is released by diffusion to delay the release of agent at a therapeutic rate for predetermined times after application. Suitable means include a delay membrane disposed between the releasing surface and the agent reservoir, which membrane is preferably free of undissolved agent and/or is initially impermeable to the agent and thereafter becomes permeable. One or more agent chambers defined by one or more of such membranes may be provided, whereby agents are released in predetermined temporal patterns at optimal release rates. Delayed permeability enables programmed washout periods to be obtained from the sequential and concurrent application of devices for the administration of drugs, such as nitrates, to which patients may develop a tolerance on continuous administration over extended time periods.

    摘要翻译： 描述了扩散药物递送装置，其可以提供治疗效果的延迟开始和以最佳速率以预定时间模式递送治疗剂。 在药剂储存器和通过扩散释放药剂的表面之间提供延迟装置，以在施用后以治疗速率延迟药剂释放预定时间。 合适的方法包括设置在释放表面和药剂储存器之间的延迟膜，该膜优选不含未溶解的试剂和/或最初不能渗透到试剂中，然后变得可渗透。 可以提供由一种或多种这样的膜限定的一个或多个试剂室，由此以最佳释放速率以预定的时间模式释放试剂。 延迟渗透性使得能够从连续和同时使用用于施用诸如硝酸盐的药物的装置获得程序性洗脱期，患者可以在延长的时间段内持续施用耐受性。

    Formulations with hydrophobic permeation enhancers
    7.
    发明授权
    Formulations with hydrophobic permeation enhancers 失效
    疏水渗透促进剂配方

    公开(公告)号：US5629019A

    公开(公告)日：1997-05-13

    申请号：US064689

    申请日：1993-05-20

    申请人： Eun Soo Lee ,  Su Il Yum ,  Michel J. N. Cormier

    发明人： Eun Soo Lee ,  Su Il Yum ,  Michel J. N. Cormier

    IPC分类号： A61K47/12 ,  A61K47/14 ,  A61K47/18 ,  A61K47/20 ,  A61K47/26 ,  A61K47/28 ,  A61K47/36 ,  A61K9/06

    CPC分类号： A61K47/26 ,  A61K47/12 ,  A61K47/14 ,  A61K47/186 ,  A61K47/20 ,  A61K47/28 ,  A61K47/36 ,  A61K9/0014 ,  Y10S514/944 ,  Y10S514/946 ,  Y10S514/951

    摘要： This invention is directed to a novel formulation for effectively utilizing hydrophobic permeation enhancers for the increased permeability of active agents through the skin or mucosa along with reduction of the lag time between application of the active agent and attainment of a therapeutically effective agent flux, with little or no irritation to the host. The invention is directed to compositions containing a hydrophobic permeation enhancer, which permeation enhancer has been micronized and stabilized in an inert carrier such as water. These compositions can be combined with a biologically active agent to provide enhanced permeability of the active agent to the skin or mucosa.

    摘要翻译： 本发明涉及一种用于有效利用疏水性渗透增强剂以增加活性剂通过皮肤或粘膜的渗透性的新型制剂，同时减少施用活性剂之间的滞后时间并获得治疗有效的药剂通量 或对主机没有刺激。 本发明涉及含有疏水渗透增强剂的组合物，该渗透增强剂已经在惰性载体如水中微粉化并稳定。 这些组合物可与生物活性剂组合以提供活性剂对皮肤或粘膜的增强的渗透性。

    Transdermal drug delivery device
    8.
    再颁专利
    Transdermal drug delivery device 失效
    透皮给药装置

    公开(公告)号：USRE39588E1

    公开(公告)日：2007-04-24

    申请号：US07606462

    申请日：1990-10-31

    申请人： Eun Soo Lee ,  Su Il Yum

    发明人： Eun Soo Lee ,  Su Il Yum

    IPC分类号： A61F3/00

    CPC分类号： A61K9/7084

    摘要： A diffusional drug delivery device is described which can provide for stability of the adhesive and system components, elimination of the initial burst of drug and hence irritation, and to provide for delayed onset of therapeutic effect along with delivery of a therapeutic agent at an optimum rate. The therapeutic agent in a first form which is suitable for storage, and the anhydrous activating means are inert when in an anhydrous environment. Moisture activates the system whereby the activating means provides an acidic or basic solution and the first form of the therapeutic agent is converted to a second form which is suitable for absorption through the skin or mucosa.

    摘要翻译： 描述了扩散药物递送装置，其可以提供粘合剂和系统组分的稳定性，消除药物的初始爆发并因此刺激，并且提供治疗效果的延迟开始以及以最佳速率递送治疗剂 。 适于储存的第一种形式的治疗剂和无水活化装置在无水环境中是惰性的。 水分激活系统，由此激活装置提供酸性或碱性溶液，并且将第一形式的治疗剂转化为适合于通过皮肤或粘膜吸收的第二种形式。

    Skin permeation enhancer compositions using acyl lactylates
    9.
    发明授权
    Skin permeation enhancer compositions using acyl lactylates 失效
    使用酰基乳酸盐的皮肤渗透促进剂组合物

    公开(公告)号：US5882676A

    公开(公告)日：1999-03-16

    申请号：US452468

    申请日：1995-05-26

    申请人： Eun Soo Lee ,  Su Il Yum

    发明人： Eun Soo Lee ,  Su Il Yum

    IPC分类号： A61K9/00 ,  A61K9/70 ,  A61K47/14 ,  A61M37/00

    CPC分类号： A61K9/7084 ,  A61K47/14 ,  A61K9/0014 ,  Y10S514/947

    摘要： The present invention is directed to the transdermal administration of a drug together with a suitable amount of an acyl lactylate permeation enhancer. The invention includes a transdermal drug delivery device comprising a matrix adapted to be placed in drug- and- permeation enhancer-transmitting relation with a skin site. The matrix contains sufficient amounts of an acyl lactylate permeation enhancer and drug, in combination, to continuously administer drug to the systemic circulation of a patient at a therapeutically effective rate. The invention is also directed to compositions and methods for transdermal administration of a drug together with an acyl lactylate permeation enhancer, alone or in combination with other enhancers.

    摘要翻译： 本发明涉及药物与适量的酰基乳酸盐渗透促进剂的透皮给药。 本发明包括透皮药物递送装置，其包括适于与皮肤部位置于药物和渗透增强剂 - 传递关系中的基质。 基质含有足够量的酰基乳酸盐渗透促进剂和药物，以治疗有效的速率将药物连续地给予患者的全身循环。 本发明还涉及用于将药物与酰基乳酸盐渗透促进剂一起或与其它增强剂组合的透皮给药的组合物和方法。

    Transdermal Administration of Tamsulosin
    10.
    发明申请
    Transdermal Administration of Tamsulosin 有权
    透明管理坦索罗辛

    公开(公告)号：US20100291186A1

    公开(公告)日：2010-11-18

    申请号：US12687586

    申请日：2010-01-14

    申请人： Parminder Singh ,  Eun Soo Lee ,  Amit K. Jain

    发明人： Parminder Singh ,  Eun Soo Lee ,  Amit K. Jain

    IPC分类号： A61K9/70 ,  A61K31/18 ,  A61P13/08

    CPC分类号： A61K31/18 ,  A61K9/0014 ,  A61K9/70 ,  A61K9/7023 ,  A61K9/7053 ,  A61K31/137 ,  A61K47/02 ,  A61K47/12 ,  A61K47/14

    摘要： In an aspect of the invention, a composition for making a patch for the transdermal delivery of tamsulosin is provided. The composition comprises (a) at least about 1 wt % tamsulosin or a pharmaceutically acceptable salt of tamsulosin, (b) at least about 40 wt % polyisobutylene adhesive or hydrophobic synthetic rubber adhesive, (c) about 1-20 wt % of an aprotic solvent in which tamsulosin dissolves readily, (d) about 1-20 wt % of an unsaturated fatty acid or an alpha-hydroxy acid or a mixture of unsaturated fatty acids or alpha-hydroxy acids or of both unsaturated fatty acids and alpha-hydroxy acids, (e) a lipophilic permeation enhancer, and (f) a matrix modifier.

    摘要翻译： 在本发明的一个方面，提供了一种用于制备用于透皮给予坦索罗辛的贴剂的组合物。 组合物包含（a）至少约1重量％的坦索罗辛或其可药用的坦索罗辛盐，（b）至少约40重量％的聚异丁烯粘合剂或疏水性合成橡胶粘合剂，（c）约1-20重量％的非质子 其中坦索罗辛容易溶解的溶剂，（d）约1-20重量％的不饱和脂肪酸或α-羟基酸或不饱和脂肪酸或α-羟基酸或不饱和脂肪酸和α-羟基酸的混合物 ，（e）亲脂性渗透促进剂，和（f）基质改性剂。